Statement Of Income

Fuji Pharma Co.,Ltd. - Filing #7610243

Concept 2021-10-01 to
2022-03-31
2020-10-01 to
2021-03-31
Statement of income
Statement of income
Net sales
17,726,000,000 JPY
17,277,000,000 JPY
Operating revenue
Net sales
Operating expenses
Cost of sales
Cost of sales
10,050,000,000 JPY
9,613,000,000 JPY
Selling, general and administrative expenses
4,963,000,000 JPY
4,977,000,000 JPY
Operating expenses
Research and development expenses
1,152,000,000 JPY
861,000,000 JPY
Operating profit (loss)
2,712,000,000 JPY
2,686,000,000 JPY
Gross profit (loss)
7,675,000,000 JPY
7,664,000,000 JPY
Non-operating income
Interest income
0 JPY
0 JPY
Gross profit
Ordinary profit (loss)
2,866,000,000 JPY
2,738,000,000 JPY
Non-operating income
207,000,000 JPY
91,000,000 JPY
Financial revenue
Non-operating income
Other
29,000,000 JPY
5,000,000 JPY
Selling, general and administrative expenses
Extraordinary income
JPY
154,000,000 JPY
Non-operating expenses
Interest expenses
44,000,000 JPY
18,000,000 JPY
Non-operating expenses
Non-operating expenses
53,000,000 JPY
40,000,000 JPY
Financial expenses
Non-operating expenses
Other
9,000,000 JPY
18,000,000 JPY
Sales discounts
JPY
3,000,000 JPY
Extraordinary losses
1,000,000 JPY
21,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
1,000,000 JPY
Profit (loss) before income taxes
2,865,000,000 JPY
2,871,000,000 JPY
Income taxes - current
848,000,000 JPY
779,000,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
1,000,000 JPY
21,000,000 JPY
Income taxes - deferred
182,000,000 JPY
70,000,000 JPY
Income taxes
1,030,000,000 JPY
849,000,000 JPY
Profit (loss)
1,834,000,000 JPY
2,022,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.